Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II
Top Cited Papers
- 1 May 2000
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 355 (9215), 1582-1587
- https://doi.org/10.1016/s0140-6736(00)02213-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- ABC of heart failure: Management: diuretics, ACE inhibitors, and nitratesBMJ, 2000
- Effects of losartan and captopril on QT dispersion in elderly patients with heart failureThe Lancet, 1999
- Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial designThe American Journal of Cardiology, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Experimental evidence to support ELITEThe Lancet, 1998
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)The Lancet, 1997
- Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?International Journal of Cardiology, 1997
- Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipne ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertensionThe American Journal of Cardiology, 1995
- Antiarrhythmic effects of ACE inhibitors: a matter of faith or reality?Cardiovascular Research, 1994
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987